Last reviewed · How we verify
Duxil (ALMITRINE)
At a glance
| Generic name | ALMITRINE |
|---|---|
| Drug class | almitrine |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Approved indications
- Chronic obstructive lung disease
Common side effects
Key clinical trials
- Almitrine in COVID-19 Patients With ARDS Treated by HFNO
- Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia (PHASE3)
- Almitrine and COVID-19 Related Hypoxemia
- Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |